NOVAVAX, INC. (NVAX) Operating cash flow 2016–2025
NOVAVAX, INC. (NVAX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$244.6MFY2025 · since FY2016: -$258.8M → -$244.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$244.6M | -180.3% |
| FY2024 | -$87.3M | +87.8% |
| FY2023 | -$714.0M | -71.7% |
| FY2022 | -$415.9M | -228.8% |
| FY2021 | $322.9M | +859.1% |
| FY2020 | -$42.5M | +68.9% |
| FY2019 | -$136.6M | +26.1% |
| FY2018 | -$184.8M | -27.9% |
| FY2017 | -$144.5M | +44.2% |
| FY2016 | -$258.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice